Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

BACKGROUND: This is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin. METHODS: This multicenter, placebo-controlled, double-blind, parallel-grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Kyung-Wan, Ku, Bon Jeong, Lee, Ji-Hyun, Kim, Min-Seon, Ahn, Kyu-Jeung, Lee, Moon-Kyu, Kokubo, Satoshi, Yoshida, Satoshi, Cho, Hyun-Ji, Cha, Bong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409005/
https://www.ncbi.nlm.nih.gov/pubmed/28447440
http://dx.doi.org/10.4093/dmj.2017.41.2.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409005/
https://www.ncbi.nlm.nih.gov/pubmed/28447440
http://dx.doi.org/10.4093/dmj.2017.41.2.135

Ejemplares similares